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KLF14 represses FOXP3 expression through an epigenetic
mechanism involving the recruitment of the HP1 family of
chromatin-modifying complexes to the promoter locus. The
lack of KLF14 results in the differentiation of peripheral/
induced T-regulatory cells and protection from colitis.
BACKGROUND & AIMS: Kruppel-like Factor 14 (KLF14) pro-
teins function as epigenetic reprogramming factors during cell
differentiation in many cell populations and in engineered
induced pluripotent stem cells. In this study, we determined the
function of KLF14 in the regulation of forkhead box protein 3
(FOXP3), a transcription factor critical for T regulatory (Treg)
cell differentiation.
METHODS: We studied the effects of KLF14 on FOXP3
expression at the level of the protein and mRNA. We evaluated
the functional relevance of KLF14 to FOXP3þ Treg cells in vitro
and in vivo through suppression assays and two colitis models.
Finally, we analyzed the effect of KLF14 on the epigenetic
landscape of the FOXP3 promoter locus through chromatin
immunoprecipitation (ChIP) assay.
RESULTS: KLF14, induced upon activation of naïve CD4þ T
cells, segregates to the FOXP3- population and is inversely
associated with FOXP3 expression and Treg function. KLF14
knockout (KO) CD4þ cells differentiated into adaptive Tregs
more readily in vitro and in vivo. KLF14 KO cells demon-
strated an enhanced Treg suppressor function in vitro
and in vivo. KLF14 repressed FOXP3 at the level of the
mRNA and protein, and by ChIP assay KLF14 was found to
bind to the Treg-speciﬁc demethylation region (TSDR)
enhancer region of FOXP3. Furthermore, loss of KLF14
reduced the levels of H3K9me3, HP1, and Suv39H1at the
TSDR.
CONCLUSIONS: These results outline a novel mechanism by
which KLF14 regulates Treg cell differentiation via chromatin
remodeling at the FOXP3 TSDR. To our knowledge, this is the
ﬁrst evidence to support a role for KLF14 in maintaining the
differentiated state of Treg cells, with an outline of a potential
mechanism to modify the expression of immune genes
such as FOXP3 that are critical to T-cell fate. (Cell Mol Gas-
troenterol Hepatol 2015;1:188–202; http://dx.doi.org/
10.1016/j.jcmgh.2014.12.007)Keywords: FOXP3; H3K9Me3; KLF14; T-regulatory cell; TSDR.
ur laboratory focuses on the role of the evolution-Oarily conserved family of Kruppel-like factor (KLF)
proteins in the differentiation of immune cells,1,2 This
important family of transcription factors is composed of 17
members characterized by the presence of their conserved
DNA-binding domain. This domain features three Cys2/His2
zinc-ﬁngers similar to Sp1 at the carboxyl terminus. The
C-terminal zinc-ﬁngers recognize and bind to the GT/GC-rich
cis-regulatory sites found in gene promoters and enhancers.
Members of the KLF family share a nuclear localization
signal sequence and a transcriptional regulatory domain
localized in their N-terminal portion. This N-terminus
is highly variable and confers functional speciﬁcity to KLF
interactions with distinct nuclear proteins. This interaction
leads to gene activation, gene repression, or both.
KLF proteins have elicited signiﬁcant attention due to
their potential use in nuclear reprogramming, a role that
leads to the acquisition and maintenance of differentiated
phenotypes in induced pluripotent stem cells. This impor-
tant feature of KLF proteins provides the medical commu-
nity with unique tools for generating differentiated cells for
use in regenerative medicine. Thus, we are optimistic that
signiﬁcant effort devoted to the study of KLF proteins in the
immune system will increase our understanding of normal
immunology, immunopathology, and immune cell therapy.
Previously, we identiﬁed a critical role for KLF10 in the
epigenetic regulation of the core promoter locus of forkhead
box protein 3 (FOXP3),1 KLF10 deﬁciency resulted in
impaired T-regulatory cell (Treg) differentiation and
March 2015 KLF14 in T Regulatory Cell Differentiation 189susceptibility to colitis. The block in Treg differentiation was
found to be Polycomb-mediated epigenetic silencing of the
FOXP3 core promoter.1 Extending our investigations into
the entire FOXP3 regulatory region, we now report a key
role for KLF14 in the maintenance of FOXP3 expression,
Treg cell function, and colitis susceptibility.
KLF14, the most recent member of the KLF family to be
identiﬁed, is a rapidly evolving imprinted gene with a clear
function in metabolism. Indeed, recently KLF14 has been
found to play a key role in lipogenesis.3 This role in fatty
acid metabolism has a profound impact in immune function,
as the metabolic pathways driving T-cell differentiation fate
are a novel, active area of research.4–8 To begin to address
this intersection between metabolism and immune cell fate,
we have for the ﬁrst time ascribed a role for KLF14 in im-
mune function. Speciﬁcally, combined cellular, biochemical,
molecular analyses, and studies in genetically engineered
mice revealed a novel KLF14-mediated function in Treg cell
differentiation.
At the molecular level, KLF14 mediated this phenome-
non, at least in part, by transcriptionally regulating FOXP3
via a mechanism that involves methylation and chromatin
remodeling of the TSDR (Treg-speciﬁc demethylation re-
gion) within the promoter of this gene. At the cellular level,
KLF14 inactivation rendered Treg cells in an abnormal state
of differentiation marked by their hypersuppressive
phenotype in vitro and in vivo. Congruently, KLF14
knockout (KO) mice were resistant to experimentally
induced colitis.
These results assign for the ﬁrst time a role for KLF14 in
immune cell differentiation and chronic intestinal inﬂam-
mation. These data also extend our understanding of mo-
lecular mechanisms that regulate Treg cell function, a
population that is altered in many disease states.
Materials and Methods
Transfection Assays
For small interfering RNA (siRNA) experiments, 300 nM
siRNA was used (ONTARGET plus siRNA; Dharmacon/
Thermo Scientiﬁc, Lafayette, CO). The cell-stimulation con-
ditions included plate-bound CD3 (2 mg/mL), soluble anti-
CD28 (2 mg/mL; BD Biosciences, San Jose, CA), and human
interleukin-2 (100 m/mL) and human transforming growth
factor b1 (TGFb1, 5 ng/mL) in complete RPMI media (both
cytokines: PeproTech, Rocky Hill, NJ).
Isolation of Primary T Cells
Male mice were used for all experiments. Murine naïve
CD4þ splenocytes were isolated using a combination of
magnetic separation kits (Miltenyi Biotec, Bergisch Glad-
bach, Germany). Sequential use of the CD4þCD25þ regula-
tory T cell isolation kit and the CD4þCD62Lþ T cell isolation
kit resulted in naïve FOXP3-negative T cells used for in vitro
induction of FOXP3.
Cell Stimulation
In vitro activation of the isolated T cells followed
similar conditions among the different cell types. Anti-CD3,145-2C11 (BD Biosciences) for the mouse T cells was plate-
bound at 2 mg/mL. Soluble anti-CD28 (BD Biosciences) at 2
mg/mL plus 100 units/mL interleukin-2 was added to the
cultures throughout the incubation period. Human TGFb1
recombinant (PeproTech) at a concentration of 5 ng/mL
was used to generate adaptive Treg cells. The media were
replaced every 3 days with cells plated into new wells
coated with anti-CD3 as described previously.
Suppression Assays
For the suppression assays, CD4þCD25þþ cells were
sorted from splenocytes, using anti-CD4/anti-CD25 conju-
gated beads (Miltenyi Biotec), as previously described
elsewhere.9 Mixed leukocyte reactions were performed us-
ing 1  104 CD4þCD25– T responder cells and 1  104
irradiated (3300 rads) T-cell-depleted antigen-presenting
cells isolated from the same animals. Treg cells were
added to the cell culture at titrations of 1:12 to 1:1. The
culture medium was complete RPMI supplemented with
10% fetal bovine serum and 2.5 mg/mL anti-CD3 (UCHT1)
and anti-CD28 (BD Biosciences) at 2 mg/mL. Proliferation
was read at 4d upon addition of 1 mCi tritiated thymidine for
the last 18 hours of culture.
RNA Isolation, cDNA Synthesis, and Quantitative
Real-Time Polymerase Chain Reaction
Total RNA was isolated using the manufacturer protocol
in the RNeasy Mini Kit (Qiagen, Valencia, CA). The cDNA was
synthesized from 0.5–1 mg of total RNA with random
primers using the SuperScript kit III First-Strand (Invi-
trogen/Life Technologies, Carlsbad, CA). We used 2 mL of
reverse-transcription products for each real-time polymer-
ase chain reaction (PCR). The PCRs were in 20 mL of total
volume that contained primers and 10 mL of Express SYBR
green ER quantitative PCR Supermaster mixes (Invitrogen).
Of note, KLF14 is an intron-less GC rich gene not optimal for
real-time PCR. Thus, for semiquantitative real-time PCR,
genes of interest were ampliﬁed under the following con-
ditions: initial denaturation, 95C for 3 minutes, followed by
34 cycles with denaturation at 95C for 30 seconds,
annealing at 55C for 60 seconds, and extension at 72C for
60 seconds. All the PCR products were visualized by
running 1.5% agarose gels electrophoresis and ethidium
bromide staining for the pictures.
The following primers were used. The Foxp3 core pro-
moter chromatin immunoprecipitation (ChIP) primers
for gels were 50-TTCAGATGACTTGTAAAGGGCAAAG and
30-GAGAAGAAAAACCACGGCGTGGGAG. The Foxp3 TSDR ChIP
primers for gels were 50-AACCTTGGGCCCCTCTGGCA and
30-GGCCGGATGCATTGGGCTTCA. The KLF14 primers were
50-TCAACTAGCTGCTTCGAGCC and 30-ACGACCTCGGTACTC
GATCA. The Foxp3 primers were 50-TTCAGATGACTTGTA
AAGGGCAAAG and 30-GAGAAGAAAAACCACGGCGTGGGAG.
Western Blot Analysis
Protein was extracted from whole-cell lysates derived
from freshly isolated Treg cells and non-Treg cells. The cells
were lysed Laemmli sample buffer. Protein (20 mg) was run
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nitrocellulose, the membrane was incubated with anti-
Foxp3 (Abcam, Cambridge, MA) in 5% milk for 1 hour.
Foxp3 protein was detected with 1/1000 dilution of anti-
rabbit-horseradish peroxidase conjugate and an electro-
chemiluminescence detection kit (SuperSignal West Femto
Chemiluminescent Kit; Pierce Biotechnology, Rockford, IL).
The exposed ﬁlms were scanned, and the digitized images
were analyzed using the software VisionWorks (UVP, Up-
land, CA). The protein signals were indexed by measuring
their relative mean grey value per area.
Chromatin Immunoprecipitation Assays
The ChIP assays were performed using a ChIP isolation
kit (Millipore, Billerica, MA). We treated 1  105 to 5  105
murine naïve T cells with 1% formaldehyde to cross-link
histones to DNA. The ﬁxed cells were sonicated to yield
chromatin fragments of 200–500 base pairs (bp). The an-
tibodies used in the ChIP assays included: H3Ac (Millipore),
H4Ac (Upstate Biotechnology, Lake Placid, NY), H3K9Ac
(Active Motif, Carlsbad, CA), H3K4Me3 (Millipore),
H3K4Me2 (Abcam), H3K4Me (Millipore), H3K9Me2 (Milli-
pore), H3K9Me3 (Abcam) H3K27me2 (Abcam) H3K27me3
(Millipore), p300 (Abcam), PCAF (Abcam), SUV39H1
(Millipore), CBP (Abcam), ESET/SetDB1(Millipore), Ezh2
(Cell Signaling Technology, Beverly, MA), G9a/EHMT2
(C6H3) (Abcam), HP1a (Millipore), HP1b (Active Motif), and
HP1g (Millipore). DNA was recovered by a Chelex 10%
slurry and sample boiling method,10 or using the IP-STAR
(Diagenode, Denville, NJ) direct chip protocol followed by
the IPPURE DNA puriﬁcation. 1% Pre-enriched chromatin
(input) served as the percentage input for sample quantiﬁ-
cation, conﬁrmed by fold over IgG changes. The UV-exposed
4% agarose gels were imaged, and the digitized images were
analyzed using the software VisionWorks (UVP). Protein
signals were indexed by measuring their relative mean grey
value per area.
Adenoviral Transduction
Naïve T cells isolated from the Coxsackie adenovirus
receptor (CAR) transgenic Balb/cJ[Tg],CARdelta1-[Tg]
DO11.10 mice were activated for 48 hours with either
empty vector (EV) or KLF14 at a multiplicity of infection of
250. The cells were activated under the typical stimulation
conditions for 2 days and processed through mRNA
expression.
Mouse Strains
C57BL/6J mice and C57BL/6J RAG-1 mice (recombi-
nase activating gene-1-deﬁcient) were initially purchased
from the Jackson Laboratory (Bar Harbor, ME) and bred in
conventional housing in the Mayo Clinic animal facility
(Rochester, MN). The CAR transgenic mouse was obtained
through the National Institute of Allergy and Infectious
Diseases Exchange Program of the National Institutes of
Health: Balb/cJ[Tg]CARdelta1-[Tg]DO11.10 mouse line
4285.11 The CAR mouse expresses the Coxsackie adeno-
virus receptor transgene and is optimal for adenoviraltransduction studies in resting lymphocytes. The KLF14/
mice were kindly provided by Dr. Raul Urrutia (Mayo Clinic,
Rochester, MN).12 All the mice used in experiments were
males of 4–20 weeks in age. The mice were age-matched in
experiments comparing wild type (WT) with KLF14/. All
animal work was done in accordance with the Mayo Clinic
Institutional Animal Care and Use Committee.
Dextran Sodium Sulfate Colitis
The mice were given water supplemented with 3%
dextran sulfate sodium salt for 5 days. The water was then
replaced with normal drinking water for 3 more days before
the mice were sacriﬁced for tissue removal for histologic
analysis. Flow cytometry was used to look at levels of
FOXP3 expression within the CD4þ population. Intracellular
staining procedures for FOXP3 were followed using the
application notes from Alexa Fluor 488 anti-mouse/rat/
human FOXP3 (BioLegend, San Diego, CA).
The mice were weighed every other day, and their colon
lengths were determined during autopsy. The degree of
colitis was quantiﬁed using three outcome variables:
weight loss, colon histology, and a disease activity index.
The disease activity index is an established clinical index of
colitis severity encompassing clinical signs of colitis
(wasting and hunching of the recipient mouse and the
physical characteristics of stool) and an ordinal scale
of colonic involvement (thickness and erythema).13 We
adapted an existing histology damage score for the dextran
sodium sulfate (DSS) colitis model.14 This score assesses
eight parameters, including the extent of crypt loss, depth
of erosions/ulcers, and semiquantitative assessment of in-
ﬂammatory cells. We added one additional parameter:
extent of re-epithelialization when erosions/ulcers were
present/expressed as ratio of re-epithelialized ulcer to
nonepithelialized ulcer.
T-Cell Transfer Model of Chronic Colitis
Chronic colitis was induced via adoptive transfer of
naïve CD4þCD45RBhigh T cells derived from WT donors
using our previously published method.15 Brieﬂy, spleens
were removed from donor WT C57BL/6J mice and macer-
ated between the frosted ends of two microscopy glass
slides to produce single-cell suspensions in phosphate-
buffered saline (PBS) supplemented with 0.1% fetal
bovine serum. The CD4þ T cells were enriched by negative
selection using magnetic beads (Miltenyi Biotec). The
enriched T cells were labeled with anti-CD45RB and anti-
CD25 (BioLegend) and sorted for CD45RBhigh CD25low
with a FACS Aria (ﬂuorescence-activated cell sorting; BD
Biosciences). We injected 3  105 cells suspended in 100
mL of PBS intraperitoneally into C57BL6J RAG-1 KO ani-
mals. After 14 days, the CD25þþ cells were isolated using
CD4þCD25þ regulatory T cell isolation kit (Miltenyi Biotec)
as described by the manufacturer’s suggested protocol
from the spleens of either WT C57BL/6J or KLF14 KO mice.
These cells were subjected to a second magnetic column
and washing step at the CD25þ step to further purify the
regulatory T-cell population (greater than 95% FOXP3þ in
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7.5  104 cells in 100 mL of PBS, which was injected
intraperitoneally into animals that had undergone adoptive
transfer of CD4þCD45RBhigh WT T cells 2 weeks earlier. The
animals were switched to nonirradiated chow, and their
weight was recorded every other day. The Mayo Clinic
Animal Facility, unless speciﬁcally directed, only uses
autoclaved and irradiated chow, but nonirradiated chow
frequently is required to induce robust colitis in this
model.16 The histologic disease activity was assessed by our
participating gastrointestinal pathologist who was blinded
to the study grouping. We adapted an existing histology
damage score for the T-cell transfer colitis model.15 This
score assesses eight parameters, including extent of crypt
loss, depth of erosions/ulcers, and semiquantitative
assessment of inﬂammatory cells.RNAseq of Human Samples
The isolation of lamina propria CD4þ lymphocytes has
previously been described elsewhere.9 Brieﬂy, resection
specimens or mucosal biopsy samples of the terminal
ileum were obtained from six patients with Crohn’s disease
or age/sex-matched healthy controls. The tissue initially
underwent mechanical disruption in the presence of 1 mM
EDTA in a 37C CO2 incubator for 30 minutes followed by aFigure 1. KLF14 is present in the immune compartment and i
FOXP3-negative lymphocytes. (A) DNA gel for polymerase c
mouse tissues. The data are a representative ﬁgure of three in
expression of KLF14 in splenocyte subsets. Note the enhanced
and CD4þ lymphocytes stimulated with TGFb (far right column).
(lower row). The data are representative of three independent ex
of KLF14 in CD4þ cells activated to induce FOXP3. Note that
negative cells at all time points. (D) Histogram representing th
represents unstimulated cells. The data are representative of
determined using the Holm-Sidak method of multiple compar
analyzed individually, without assuming a consistent standard dcollagenase (1 mg/mL), DNase (1 mg/mL), and trypsin
inhibitor (1 mg/mL) overnight at 4C in complete RPMI
supplemented with 10% human serum. After passage
through a 70-mm cell strainer, the buffy coat was isolated
using Ficoll gradient centrifugation. The CD4þ lamina
propria cells were isolated using magnetic bead sorting
(CD4þ T Cell Isolation kit, 130–091–155; Miltenyi Biotec)
and two passes through the LS column on the MACS
magnetic separator. Puriﬁcation was conﬁrmed by ﬂow
cytometry.
Sequencing data was analyzed using the processed
paired-end mRNA sequencing analysis using the MAP-RSeq
v1.2.1.3 workﬂow (Mayo Clinic, Rochester, MN). This anal-
ysis provided gene and exon level expression. We performed
differential expression analysis using edgeR (Bioconductor,
Bioconductor.org) for the following disease versus control.Statistical Methodology
Statistical analyses were performed using JMP
version 9.0 (SAS Institute, Cary, NC). Nonparametric un-
paired t test was performed using the Mann-Whitney t
test, and P < .05 was considered statistically signiﬁcant.
For multiple comparisons, statistical signiﬁcance was
determined using the Holm-Sidak method, with alpha ¼
5.000% (P < .05). Each variable was analyzednduced by transforming growth factor b1 (TGFb) in vitro in
hain reaction (PCR) analysis of the expression of KLF14 in
dependent experiments. (B) DNA gel for PCR analysis of the
expression of KLF14 in CD4þ lymphocytes (right four panels)
The housekeeping gene gapdh is provided as loading control
periments. (C, D) DNA gel for PCR analysis of the expression
KLF14 expression segregates to GFP (surrogate for FOXP3)
e optical density of gel bands. Note that time 0 (grey bar)
three independent experiments. Statistical signiﬁcance was
isons, with alpha ¼ 5.000% (P < .05). Each time point was
eviation.
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deviation (SD).Results
KLF14, Present in Immune Cells, Is Inversely
Associated With FOXP3
The expression pattern of KLF14 in immune tissue is
currently unknown, precluding us from inferring any poten-
tial function of this protein in the immune system. Conse-
quently, we performed an expression analysis from various
murine tissue extracts to gain insight into the spatial distri-
bution of this transcription factor. KLF14 mRNA was ubiq-
uitous in murine tissues, with particularly strong expression
in primary and secondary lymphatic organs (Figure 1A).Figure 2. KLF14 deﬁciency in CD4D lymphocytes results i
expressed as a percentage of CD4þ cells in central and peripher
cells within gut-associated lymphoid organs (mesenteric lymph n
Peyer’s patches [PP] WT vs KLF14 KO, 4.6% ± 0.3% vs 6.1%
mean of ﬁve WT and 5 KLF14 KO mice. A nonparametric, unp
Whitney) demonstrated no statistically signiﬁcant difference. (B
for 5 days with T-cell receptor (TCR) and transforming growth
(32.7% vs 17.8%, KLF14 KO vs WT) in KLF14-deﬁcient T cells. T
(C) Mean ﬂuorescent intensity for FOXP3 (FL-1 channel) in induc
ﬂuorescent intensity in KLF14 KO in the in vitro differentiated Tr
The results represent the mean/standard error of the mean
nonparametric, unpaired t test of signiﬁcance between WT and
cance (P < .05).Within the spleen, KLF14 expression segregated to
CD4þ lymphocytes, a ﬁnding that suggested a putative
role for KLF14 in the differentiation of CD4þ T helper
phenotypes (Figure 1B). We stimulated naïve CD4þ lym-
phocytes into adaptive Treg cells (see Materials and
Methods) and measured KLF14 expression (Figure 1B).
After 72 hours of activation, KLF14 was induced by TGFb1
and up-regulated within the entire population of CD4þ
cells (right column, Figure 1B). Upon separation of CD4þ
cell subsets based upon FOXP3 expression, we demon-
strated an inverse relationship between FOXP3 and
KLF14 (Figure 1C and D). Together, these studies
demonstrate that KLF14, enriched in immune organs and
cells is induced during the initial differentiation of
naive lymphocytes to adaptive Treg cells; however, KLF14n up-regulation of FOXP3. (A) Flow cytometry for FOXP3,
al lymphatic organs. Note the numerical difference in FOXP3þ
odes [MLN] WT vs KLF14 KO, 5.6% ± 0.8% vs 7.1% ± 0.3%;
± 0.7%). The data represent the mean/standard error of the
aired t test of signiﬁcance between lymphoid organs (Mann-
) Flow cytometry for FOXP3 in CD4þ lymphocytes stimulated
factor b1 (TGFb). Note the enhanced expression of FOXP3
he data are representative of three independent experiments.
ed T regulatory (Treg) cells. Note the signiﬁcantly higher mean
eg cells (50.5 ± 1.7 vs 43.7 ± 1.5, KLF14 KO vs WT, P ¼ .04).
ﬂuorescent intensity of three independent experiments. A
KLF14 KO (Mann-Whitney) demonstrated statistical signiﬁ-
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led us subsequently to investigate the impact of KLF14
gene deletion on the biological responses of differentiated
Treg cells.Expression of KLF14 Is Inversely Correlated With
FOXP3 Expression and Function In Vivo
A survey of the principal immune components of the
KLF14 KO mouse demonstrates a normal CD4:CD8 ratio and
normal populations of CD19þ and CD11bþ cells (B cell and
myeloid lineage, respectively) within the spleen when
compared with age- and sex-matched control mice
(Supplementary Figure 1). We did observe numerically
higher but not statistically signiﬁcantly different percent-
ages of FOXP3þ cells (expressed as a percentage of CD4þ
lymphocytes) in mucosal-associated lymphoid tissue
(mesenteric lymphatic nodes [MLN] and Peyer’s patches
[PP], Figure 2A).
Upon stimulation of naïve CD4þ splenocytes to differ-
entiate into adaptive Treg cells (see Materials and Methods),
we observed a higher frequency of FOXP3þ cells in vitro in
the absence of KLF14 (Figure 2B). Furthermore, intracel-
lular expression of FOXP3 is enhanced as assessed by meanFigure 3. KLF14 KO animals are resistant to dextran sodium
colon length, (C) clinical disease activity scores, and (D) histolo
less severe colitis in KLF14-deﬁcient (closed circles) versus wild
section from the colon of a KLF14-deﬁcient mouse compared wi
the colon of a WT mouse (D). Statistical signiﬁcance for weight
alpha ¼ 5.000% (P < .05). Each time point was analyzed individ
colon length and disease activity index, signiﬁcance was dete
signiﬁcance (Mann-Whitney), P < .05. The data are representatﬂuorescent intensity in KLF14 KO Treg cells (Figure 2C).
Enhanced differentiation into FOXP3þ T cells in the absence
of KLF14 was not due to altered kinetics of cellular prolif-
eration, as naïve lymphocytes from WT or KLF14 KO mice
proliferated equally as assessed by ﬂuorescence-activated
cell sorting and intracellular dye dilution (Supplementary
Figure 2). Similar proliferation between WT and KLF14
KO cells was seen in both FOXP3þ and FOXP3- cell pop-
ulations (Supplementary Figure 3).
To study the functional relevance of this in vitro ﬁnding,
we evaluated mucosal immune response to DSS. Although
not speciﬁc for adaptive immune cell function, the DSS-
induced colitis model is a well-established tool to study
mucosal inﬂammation in genetically engineered mice,
including those deﬁcient in KLF proteins.1 Thus, we
assessed the development and severity of colitis by DSS in
KLF14 KO mice by measuring weight loss, colon length,
disease activity index, and histopathology. Interestingly, we
found that upon DSS treatment, KLF14 KO mice displayed
statistically signiﬁcantly less weight loss (28.0 ± 1.1 g
vs 23.5 ± 0.99 g, P ¼ .001), reduced colonic shortening
(6.8 ± 0.6 cm vs 4.9 ± 0.5 cm, P ¼ .0007), and lower clinical
disease activity scores as compared with the WT control
animals (0.69 ± 0.73 vs 2.13 ± 0.86, P ¼ .02) (Figure 3A–C).sulfate (DSS) colitis. Tabulation of (A) weight change, (B)
gic disease in DSS-exposed mice demonstrates signiﬁcantly
type (WT) (open circles) animals. (D) Representative histologic
th the signiﬁcant inﬂammation and ulceration demonstrated in
change was determined using the Holm-Sidak method, with
ually, without assuming a consistent standard deviation. For
rmined using a nonparametric, unpaired t test of statistical
ive of three experiments, n ¼ 5 mice per group.
Figure 4. KLF14-deﬁcient T regulatory (Treg) cells demonstrate enhanced suppression in vitro. (A) Histogram repre-
senting thymidine incorporation of T-responder cells in coculture with T-regulatory cells isolated from wild-type (WT) (white
columns) or KLF14 knockout (KO) mice (black columns). Note the enhanced suppression of proliferation across all titrations,
signiﬁcantly so upon higher titration ratios (WT vs KLF14 KO: 7595 ± 906 vs 5099 ± 647, 1:3; 5948 ± 1488 vs 3158 ± 716, 1:2;
4804 ± 1833 vs 1349 ± 223, 1:1, P < .05). Presented are the mean and standard deviation (SD) of thymidine counts conducted
in triplicate. Data are representative of three independent experiments. Statistical signiﬁcance was determined using the Holm-
Sidak method, with alpha ¼ 5.000% (P < .05). Each titration was analyzed individually, without assuming a consistent SD. (B)
Enhanced in vitro suppression of KLF14-deﬁcient Treg cells associated with greater expression of FOXP3. Demonstrated is
the immunoblot analysis (upper row) and DNA gel (lower row) for FOXP3 protein (upper) and mRNA (lower) in Treg cells after 3
days of suppression assay culture. Note the heightened expression of FOXP3 in KLF14 KO cells compared with WT. Data are
representative of three independent experiments.
Figure 5. KLF14 knockout (KO) T-effector cells induce colitis. Tabulation of (A) weight change, (B) colon length, and (C)
clinical disease activity scores in CD45Rbhigh transferred RAG recipients. Results demonstrate equivalently severe colitis in
RAG recipients of KLF14 KO (closed circles or histogram) and wild-type (WT) (open circles or histogram) CD45Rbhigh T cells. (D)
Representative histologic sections from the colon of a recipient of KLF14 KO T cells (top panel) compared with the colon of a
recipient of WT T cells (lower panel). Immunohistochemical analysis for FOXP3 demonstrates the presence of FOXP3þ lym-
phocytes in recipients of KLF14 KO T cells. Data from n ¼ 10 mice, 5 per treatment group (mean and standard deviation). A
nonparametric, unpaired t test of signiﬁcance between genotypes (Mann-Whitney) demonstrated no statistically signiﬁcant
difference.
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Figure 6. KLF14-deﬁcient T regulatory (Treg) cells demonstrate enhanced suppression in vivo. Tabulation of (A) weight
change, (B) clinical disease activity scores, and (C) histologic disease activity index in CD45Rbhigh transferred RAG recipients
after treatment with WT or KLF14 KO Treg cells. The results demonstrate signiﬁcantly less severe colitis in recipients of KLF14-
deﬁcient (closed circles or histogram) versus wild-type (WT) (open circles or histogram) Treg cells. (D) Representative histologic
sections from the colon of a recipient of KLF14 KO Treg cells compared with the signiﬁcant inﬂammation and ulceration
demonstrated in the colon of a recipient of WT Treg cells. Statistical signiﬁcance for weight change was determined using the
Holm-Sidak method, with alpha ¼ 5.000% (P < .05). Each time point was analyzed individually, without assuming a consistent
standard deviation (SD). For the disease activity index and histologic activity index, statistical signiﬁcance was determined
using a nonparametric, unpaired t test of signiﬁcance (Mann-Whitney), P < .05. Data from n ¼ 10 mice, 5 per treatment group
(mean and SD, *P < .05).
March 2015 KLF14 in T Regulatory Cell Differentiation 195The development of colonic inﬂammation was conﬁrmed by
blinded histologic examination of the colons. In comparison
with the WT control animals, the colon of the DSS-treated
KLF14 KO mice contained fewer inﬂammatory cells,
reduced ulceration (11.4% ± 4.17% vs 30.7% ± 8.8%, P ¼Figure 7. SP6 (KLF14) is inversely associated with Foxp3 in C
performed gene expression analysis on CD4þ cells isolated fro
open circles). Note the inverse relationship between FOXP3 an
analysis using edgeR for disease versus control at a false-disc.02, for n ¼ 7 animals), and enhanced re-epithelialization
(83.3% ± 28.8% vs 36.2% ± 6.5%, P ¼ .02, for n ¼ 7 ani-
mals; Figure 3D). These observations demonstrate that ge-
netic inactivation of KLF14 in the germ line confers
protection from experimental colitis. We recognize theD4D cells isolated from patients with Crohn’s disease.We
m affected (CD, closed circles) and unaffected tissue (CTRL,
d KLF14 (n ¼ 10 subjects, P < .05). A differential expression
overy rate of <0.05 was used.
Figure 8. KLF14 binds to the TSDR (Treg-speciﬁc demethylation region) and is a transcriptional regulator of FOXP3.
DNA gels for polymerase chain reaction (PCR) analyses of expression of FOXP3 in naïve CD4þ lymphocytes after siRNA
knockdown (KO) (A) or adenoviral overexpression (B) of KLF14. Note that knockdown of KLF14 leads to enhanced FOXP3
expression (A) whereas overexpression, particularly in the setting of transforming growth factor b1 (TGFb) stimulation, leads to
repression of FOXP3 (B). Similarly, freshly isolated splenocytes and naïve CD4þ lymphocytes from the KLF14 KO animal
demonstrate enhanced FOXP3 expression when compared with the wild type (WT) (C). Data are representative of three in-
dependent experiments. (D) DNA gel for PCR using primers speciﬁc for the TSDR within the FOXP3 locus in samples after
precipitation for KLF14-His in murine naïve CD4þ splenocytes after overexpression with either KLF14-His or empty vector (EV).
Note the ready identiﬁcation of KLF14 at the TSDR as compared to the empty vector control. Data are representative of three
independent experiments.
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its lack of speciﬁcity for adaptive immune cells, so we
focused further study of KLF14 and colitis in T-cell-depen-
dent assays.
We next tested the in vitro suppressor function of iso-
lated Treg cells from both WT and KLF14 KO animals
against titrated T-responder cells (Figure 4A and
Supplementary Figure 4). The results of these experiments
demonstrated an enhanced KLF14 KO Treg cell suppressor
function (counts per minute 1349 ± 223.2 vs 4804 ±
1833.2, P ¼ .03; KL14 KO vs WT at 1:1 ratio). The sup-
pression assay was performed using alternatively synge-
neic T-responder cells (Figure 4A) and a common
T-responder cell population (Supplementary Figure 4)
with equivalent results. As the cellular abundance of
FOXP3 correlates with function,17,18 we quantiﬁed FOXP3
in WT and KLF14 KO Treg cells in cell culture conditions
established for the suppression assay. Figure 4B shows
that deletion of KLF14 increased the expression of FOXP3
at both the protein (top row, Figure 4B) and the mRNA
level (bottom row, Figure 4B).
Subsequently, we tested the in vivo suppressor function
of KLF14 KO Treg cells. We used the CD4þCD45RBhigh T cellinto RAG KO (Rbhigh transfer) model of colitis.19 To rule out
an effect of KLF14 in the T-effector cells in vivo, we ﬁrst
performed a Rbhigh transfer using naïve cells from WT or
KLF14 KO donor mice. The transfer of naïve CD4þ T cells
from both WT and KLF14 KO donor mice resulted in equally
severe colitis (Figure 5). In support of our previous in vitro
data of enhanced conversion of naïve T cells to Treg cells in
the absence of KLF14, we did detect more FOXP3þ cells
within the colon of recipients of KLF14 KO T cells when
compared to WT by immunohistochemical analysis
(Figure 5).
Next, to directly test the in vivo function of KLF14 KO
Treg cells, we performed adoptive transfer of WT or KLF14
KO Treg cells into mice with established disease. Treg cells
were isolated from the spleens of WT or KLF14 KO mice
after CD25 magnetic bead selection (see Materials and
Methods). Two weeks after the CD45Rbhigh transfer of WT
naïve T cells, 75,000 WT or KLF14 KO Treg cells were
transferred into RAG KO recipient animals to stringently test
the extraordinary in vivo Treg function. We assayed colitis
in the mice by measuring weight loss, colon length, disease
activity index, and histopathology. Mice rescued with KLF14
KO Treg cells experienced statistically signiﬁcantly more
Figure 9. KLF14 associates with H3K9me3 histone marks
and the corresponding histone methyltransferase complex
at the TSDR. Semiquantitative polymerase chain reaction
chromatin immunoprecipitation analysis of the expression
of FOXP3 in cell fractions after immunoprecipitation for
H3K9me3, HP1g, SUV39H1, and HP1b in naïve T cells at t ¼
0 hours and 24 hours after transforming growth factor b1/T
regulatory (TGFb-Treg) stimulating conditions. Note the as-
sociation of H3K9me3, HP1g, HP1b, and SUV39H1 with the
wild-type (WT) but not KLF14 knockout (KO) Treg cells. The
data are representative of three independent experiments.
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original weight ± 8.1%, P ¼ .03), reduced colonic shortening
(8.21 ± 0.43 cm vs 7.05 ± 0.34 cm, P ¼ .0004), and lower
clinical disease activity scores as compared with the WT
Treg-injected control animals (2.25 ± 0.80 vs 5.50 ± 1.45
P ¼ .0008) (Figure 6). Furthermore, animals injected with
KLF14 KO Treg cells had statistically signiﬁcantly lessFigure 10. Lack of association with either G9a or
H3K27me3 at the TSDR (Treg-speciﬁc demethylation re-
gion) in relationship to KLF14 genotype. Semiquantitative
polymerase chain reaction chromatin immunoprecipitation
analysis of the expression of FOXP3 in cell fractions after
immunoprecipitation for H3K27me3 and G9a in naïve T cells
at t ¼ 0 hours and 24 hours after transforming growth factor
b1/T regulatory (TGFb-Treg) stimulating conditions. Note
there are no differences in the levels of the methlytransferase
G9a or the Polycomb-associated mark H3K27me3. The data
are representative of three independent experiments.cellularity of their mesenteric lymph nodes (4.4  106 ±
1.9  106 vs 2.2  106 ± 9.6  105, P ¼ .03) than the WT
Treg injected animals. The development of colonic inﬂam-
mation was conﬁrmed by blinded histologic examination of
the colons. In comparison with the WT Treg-injected control
animals, the colon of the KLF14 KO Treg-injected mice
contained fewer inﬂammatory cells and reduced ulceration/
erosion and crypt loss, resulting in a statistically signiﬁ-
cantly reduced histologic index of colitis (11.6 ± 3.29 vs
1.8 ± 0.45, P ¼ .0002, n ¼ 10, n ¼ 5 animals per treatment
group) (Figure 6).
Combined, our in vivo and in vitro experiments
demonstrated that deletion of KLF14 results in an abnormal
increase in the intracellular levels of FOXP3 and enhanced
suppressive function of Treg cells in vitro and in vivo.
Moreover, gene expression analysis of CD4þ lymphocytes
isolated from Crohn’s disease intestinal lesions demon-
strated KLF14 (alias SP6) to be inversely associated with
FOXP3 and differentially regulated between Crohn’s pa-
tients and healthy controls (Figure 7). This ﬁnding suggests
a potential role for KLF14 in human inﬂammatory disease as
well. As stable FOXP3 expression is necessary to maintain
the fully differentiated state of Treg cells,20 and epigenetic
modiﬁcations of the TSDR are associated with stable FOXP3
expression, we subsequently studied the epigenetic state of
the TSDR.KLF14 Is a Transcriptional Repressor of
FOXP3 Acting via the Treg-Speciﬁc
Demethylated Region
Our experiments in genetically engineered KLF14 KO
Treg cells revealed an inverse correlation between KLF14
and maintenance of FOXP3 expression, the master regulator
of Treg cell differentiation. To rule out the possibility that
the up-regulation of FOXP3 is not simply a compensatory
response to the deletion of KLF14 in the germ line, we
performed complimentary experiments overexpressing and
knocking down KLF14. We performed acute depletion of the
KLF14 mRNA using siRNA-based knockdown. The results of
these experiments, shown in Figure 8A, demonstrated that
acute depletion of KLF14 by siRNA increased FOXP3
expression.
Reciprocal overexpression experiments were performed
using adenoviral transduction of KLF14 into primary naïve
CD4þ lymphocytes. Figure 8B shows that overexpression of
KLF14 decreased Foxp3 expression in both resting (Naïve
Ts-TGFb1) and stimulating conditions (Naïve TsþTGFb1).
Thus, both genetic approaches—in vivo knock out
(Figure 8C) and in vitro knock down of KLF14—link the
function of this transcription factor to the regulation of
FOXP3 gene expression and maintenance.
To test whether KLF14 regulated FOXP3 directly, we
performed ChIP assays in primary naive T cells. Upon
adenoviral transduction of KLF14-His into primary naïve
CD4þ lymphocytes, we demonstrated that KLF14 bound to
the FOXP3 promoter locus, and speciﬁcally within the TSDR
(Figure 8D). Together these experiments demonstrated that
KLF14 is normally bound to the TSDR during cell
Figure 11. KLF14 associates with H3K9me3 histone marks and the corresponding histone methyltransferase complex at
the TSDR in freshly isolated CD25D T regulatory (Treg) cells. Quantitative real-time polymerase chain reaction analysis of
the expression of FOXP3 in cell fractions after immunoprecipitation for (A) H3K9me3, (B) HP1g, or (C) SUV39H1 in primary
CD4þ T-cell subsets. Note the signiﬁcant association of H3K9me3 (8.04 ± 1.09 vs 2.84 ± 0.65 fold change, P < .05), HP1g
(0.73 ± 0.07 vs 0.30 ± 0.07 fold change, P < .05), and SUV39H1 (0.63 ± 0.07 vs 0.30 ± 0.06 fold change, P < .05) with the wild-
type (WT CD25þ) but not KLF14 knockout (KLF14 KO CD25þ) Treg cells. The data represent the mean/standard error of the
mean of three independent experiments. Statistical signiﬁcance was determined using a nonparametric, unpaired t test of
signiﬁcance (Mann-Whitney), P < .05.
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the absence of KLF14, FOXP3 expression and Treg sup-
pressor capacity were enhanced; thus, we subsequently
evaluated the potential for KLF14 to regulate chromatin
modiﬁcation of the TSDR.Regulation of the FOXP3 Locus by KLF14
Involves Chromatin Remodeling of the
Treg-Speciﬁc Demethylated Region
It has recently been demonstrated that stable Foxp3
expression, like the one that is observed in thymus-derived,
terminally differentiated Treg cells, is marked by epigenetic
modiﬁcations of the Treg-speciﬁc demethylated region
(TSDR), a CpG-rich, noncoding sequence within the ﬁrst
intron of the Foxp3 gene locus.21 Based on this knowledge,
we reasoned that KLF14 potentially inﬂuences FOXP3
expression by mediating changes in the levels of both his-
tone marks and CpG island methylation within thisregulatory module. Consequently, we examined whether
KLF14 changes the levels of histone marks associated with
nucleosomes present on the TSDR.
We performed ChIP-based analyses of this region upon
differentiation of naïve CD4þ lymphocytes to induce FOXP3.
Of interest, stimulation over 24 hours in conditions to
induce FOXP3 led to H3K9me3 marks deposited on the
TSDR of WT but not KLF14 KO CD4þ lymphocytes
(Figure 9). Congruently, the H3K9me3 mark was associated
with the responsible histone methyltransferase (SUV39H1,
Figure 9) and the HP1 family of epigenetic transcriptional
repressors recruited through binding to the H3K9me3 mark
(HP1b, HP1g, Figure 9).22,23 Control experiments demon-
strated that this variance in H3K9me3 levels between WT
and KLF14 KO cells was accompanied by the expected in-
verse relationship with the preceding H3K9 dimethylation
mark (Supplementary Figure 5).
Subsequent experiments evaluating additional chro-
matin repressor complexes demonstrated no speciﬁc
Figure 12. Pyrosequencing of the TSDR (Treg-speciﬁc demethylation region) in T-regulatory (Treg) cells from wild-type
(WT) and KLF14 knockout (KO) mice during Treg differentiation. We directly measured the levels of methylation at the
TSDR by pyrosequencing using genomic DNA of naïve T cells isolated from KLF14 KO and WT animals at T ¼ 0 (naïve T cells)
and after 48 hours, 5 days, and 9 days of Treg-stimulating conditions (CD25 cells used as controls). We conﬁrmed decreasing
methylation of CpG sites (labeled 1–15) within the FOXP3 TSDR over time in both WT and KLF14 KO cells. Residues 7 and 11
are demonstrated in red. Data are representative of three independent experiments.
March 2015 KLF14 in T Regulatory Cell Differentiation 199association with the H3K9 methyltransferase G9a or addi-
tional repressor marks (H3K27me3, Figure 10). We per-
formed conﬁrmatory analyses of freshly isolated Treg cells
from WT and KLF14 KO donor mice. Using ChIP assay and
quantitative real-time PCR, we conﬁrmed the association of
the H3K9me3 marks, the HMT SUV39H1, and HP1g with the
TSDR of WT but not KLF14 KO freshly isolated Treg cells
(CD25þ, Figure 11). It is established that H3K9me3 marks
may lead to DNA methylation. We performed pyrose-
quencing of the TSDR in Treg cells from WT and KLF14 KO
animals demonstrating variance in methylation of critical
CpG residues (Figure 12). We conclude, that congruent with
a role as a transcriptional repressor of FOXP3, deletion of
KLF14 results in higher levels of expression for this target
gene via a mechanism that involves, at least in part, chro-
matin remodeling at the TSDR.Discussion
Kruppel-like transcription factors orchestrate complex
physiologic and pathologic phenotypes by regulating selec-
tive gene expression networks through DNA binding andcoupling to chromatin-remodeling enzymes. These
biochemical properties are critically linked to the epigenetic
reprogramming of gene expression that must occur during
the functional capacitation of most cell types. During the
generation of induced pluripotent stem cells, KLF4 best il-
lustrates these KLF family properties. However, many
members of the KLF family support cell differentiation in a
large variety of tissues.
Relevant to our current study, several recent in-
vestigations have indicated an important role for KLF
proteins in the functional regulation of immune cell types.
Indeed, KLF2, KLF13, and KLF10 have been implicated in
the development of T cells, B cells, and Treg cells,
respectively.24–35 However, the full repertoire of KLF
proteins regulating immune cell differentiation and func-
tion has yet to be established. To begin ﬁlling this
knowledge gap, our laboratory and others have been
studying the role of KLF proteins in FOXP3-mediated
differentiation of Treg cells, the proper execution of
which is critical for the maintenance of immune self-
tolerance. We observed that KLF14 is expressed at the
time that induced Treg cells commence their
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ated with human inﬂammatory diseases, including type 2
diabetes and atherosclerosis,36 but until now has not been
speciﬁcally found to act in the immune compartment. We
found KLF14 to be highly expressed within primary and
secondary lymphatic organs, segregating within the CD4þ
lymphocytes, which suggests a putative role for KLF14 in
T-helper phenotypes. One such phenotype, the FOXP3þ
Treg cell, is of great interest within the ﬁeld of immune-
mediated disease.
Mutations in Foxp3 result in the devastating and lethal
immune dysregulation, polyendocrinopathy, enteropathy
X-linked (IPEX) syndrome, which is characterized by an
overwhelming systemic autoimmune reaction in the ﬁrst
year of life.11,37–40 Indeed, point mutations of FOXP3 have
been recently identiﬁed in cases of familial refractory IBD-
like disease.12 Therefore, understanding the epigenetic
mechanisms regulating FOXP3 is of upmost importance.
We found KLF14 to be a repressor of FOXP3 through the
epigenetic regulation of the TSDR region of the promoter
locus. Incomplete data exist regarding the negative regula-
tion of FOXP3. Genetic mutant mouse lines have suggested T-
cell receptor (TCR)-dependent signaling pathways (tyrosine
kinase Itk41 and cytokine responsive genes [IRF-1]),42 to
repress FOXP3 gene transcription; however, little mecha-
nistic information particularly relating to epigenetic events
was reported. We examined the role for KLF14 in chromatin-
dependent mechanisms leading to epigenetic regulation at
this locus. KLF14 strongly bound the TSDR in ChIP assays; in
its absence, Foxp3 expression was enhanced. Thus, we
looked for its effect on the chromatin landscape at the TSDR.
Compelling evidence has established demethylation at the
TSDR to be required for long-term maintenance of FOXP3
expression in Tregs.20,43,44 However, the preceding signaling
events, speciﬁcally the chromatin-mediated events leading to
TSDR methylation, remain unknown. Loss of KLF14 results
in reduced levels of H3K9me3 and hypomethylation at the
TSDR. Interestingly, Polansky et al45 reported of the 15 CpG
motifs in the TSDR that only 6, 7, 11, and 13 are essential for
FOXP3 transcriptional activity as determined by luciferase
reporter analysis. In our pyrosequencing comparison of
pooled KLF14 KO and WT naïve cells taken at time 0 and
after 48 hours, 5 days, and 9 days of Treg-inducing condi-
tions, we found numerical variance in CpG motifs 7 and 11.
Further work into the kinetics of this process is warranted.
Therefore, deletion of KLF14 at the promoter region results
in higher levels of Foxp3 gene expression via a mechanism
that involves chromatin remodeling at the TSDR.
Interestingly, H3K9 methylases have been previously
described to repress FOXP3 through epigenetic modiﬁcation
of the core promoter region under the direction of the SUMO
E3 ligase, PIAS-1.46 This function was found to be relevant to
natural Treg cells. Recently, the methyltransferase G9A was
found to regulate T-cell differentiation during intestinal
inﬂammation, causing a similar promotion in Treg differen-
tiation program in its absence similar to what we ﬁnd with
KLF14 deﬁciency.47 Our study is the ﬁrst to deﬁne a role for
H3K9 methylase complexes in TGFb1-inducible adaptive
Treg cells through epigenetic silencing at the TSDR. Thus, acommon epigenetic regulatory complex may function to
regulate both natural and adaptive Treg cells, and further
research is warranted into the mechanisms of speciﬁcity of
recruitment to precise FOXP3 promoter domains.
Sphingosine-kinase-1 (S1P1) has been shown to be
activated by KLF14 in endothelial cells and to play impor-
tant roles in T-cell trafﬁcking48 and thymus egress.49,50 Of
particular interest, Liu et al5 found that S1P1 blocks the
differentiation of Treg cells and that this difference was not
due to proliferation of Treg cells, as we have demonstrated
here. Although we cannot rule out synergistic effects of
KLF14 acting indirectly through S1P1 in our system, we do
show that KLF14 directly acts upon the Foxp3 locus through
an epigenetic mechanism.
Given our interest in adaptive Treg cells and the TGFb1-
rich milieu of the intestine, we previously identiﬁed the
mechanism leading to colitis susceptibility in KLF10 KOmice
to result from Polycomb-mediated epigenetic silencing of
FOXP3. As opposed to the block in adaptiveTreg generation in
the KLF10 KO mouse,1,2 the lymphocytes from the KLF14 KO
mouse readily convert to adaptive Treg cells anddemonstrate
enhanced suppressor function in vitro and in vivo. KLF14
deﬁciency is associated with protection from colitis, and
interestingly KLF14 is also inversely associated with FOXP3
in T cells isolated from patients with Crohn’s disease. KLF10
and KLF14, members of the same family and both induced by
TGFb, recruit different histone-modifying complexes and, as
demonstrated in our current and previous publications, bind
to different elements of the FOXP3 promoter locus.1,2 These
data suggest that the KLF network-regulating T-cell differ-
entiation has relevance to intestinal homeostasis and colitis.
In conclusion, we previously demonstrated that KLF10
directly regulates the promoter of FOXP3 in vivo and that
alteration of this process impairs Treg cellular differentia-
tion, leading to the development of autoimmunity. As a direct
extension of these studies, we now report that KLF14, a
protein structurally and functionally related to KLF10, also
regulates the differentiation and functional specialization of
Treg cells. Our ﬁndings demonstrate, for the ﬁrst time, that
1) KLF14 is highly expressed in the immune system, in
particular in Treg cells, where it functions as a transcrip-
tional repressor of the FOXP3 gene; 2) KLF14 KO mice,
which carry hypersuppressive Treg cells, are protected from
experimentally induced colitis; and 3) the increase in FOXP3
levels observed in KLF14 KO Treg cells involves epigenetic
modiﬁcations at the TSDR, the intronic enhancer region
associated with stable expression of this gene. This work
furthers our knowledge into how FOXP3 is repressed and/or
silenced during Treg cell differentiation and lineage deter-
mination, and/or in conditions of immunopathogenesis.
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Supplementary Figure 1. KLF14 KO mice demonstrate
normal CD4:CD8 ratio and normal populations of CD19D
and CD11bD cells within the spleen when compared to
age- and sex-matched control mice. The histogram rep-
resents results from ﬂow cytometric analysis of splenocytes
for CD4, CD8, B cell (CD19), and myeloid (CD11b) lineage
cells. Note no demonstrable differences in above subsets
(WT open histogram, KLF14 KO closed histogram). The data
represent the mean/standard error of the mean of three in-
dependent experiments. A nonparametric, unpaired t test of
signiﬁcance between lymphoid organs (Mann-Whitney)
demonstrated no statistically signiﬁcant difference.
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Supplementary Figure 2. KLF14 KO CD4D T cells demonstrate normal kinetics of proliferation. Histograms represent
ﬂuorescent intensity of CellTrace Violet in naïve KLF14 KO (upper panels) and WT (second row) CD4þ T cells after stimulation
with TCR and TGFb for 24 (left column) or 48 hours of stimulation. Note the similar proﬁles of ﬂuorescent dilution with sub-
sequent cell proliferative cycles between KLF14 KO versus WT. Quantitation of lymphocytes present in ﬂow cytometric gates
in triplicate experiments is presented in histograms below. Note no signiﬁcant differences between KLF14 KO (open histogram)
and WT (closed histogram) cells represented within each cell division. The experiment was performed in triplicate and his-
tograms represent mean/standard error of the mean of all data. Multiple t test analysis was performed using the Holm-Sidak
method, with alpha ¼ 5.000% (P < .05). Each time point was analyzed individually, without assuming a consistent standard
deviation. No statistically signiﬁcant difference between genotypes was evident.
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Supplementary Figure 3. KLF14 KO CD4D FOXP3D T cells demonstrate normal kinetics of proliferation. Dot plots
represent ﬂuorescent intensity of CellTrace Violet in naïve KLF14 KO (upper panels) and WT (lower panels) CD4þ T cells after
stimulation with TCR and TGFb for 24 (left column), 48 (middle column), or 72 (right column) hours of stimulation. FOXP3þ cells
are GFPþ cells on the y axis, and the box represents FOXP3þ cells expressed as a percentage of CD4þ cells. Note the similar
proﬁles of ﬂuorescent dilution with subsequent cell proliferative cycles between KLF14 KO versus WT FOXP3þ cells and, as
observed previously, the higher percentage of FOXP3þ cells in the KLF14 KO cells. The experiment was performed in triplicate,
and all data are shown.
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Supplementary Figure 4. KLF14-deﬁcient T-regulatory
(Treg) cells demonstrate enhanced suppression in vitro.
Histogram represents thymidine incorporation of T responder
cells (WT) in coculture with Treg cells isolated from WT (black
column) or KLF14 KO mice (grey column) normalized to WT.
1:1 ¼ 60% reduction, P ¼ .0002; 1:2 ¼ 41% reduction, P ¼
.002; 1:3 ¼ 40% reduction, P ¼ .004; 1:4 ¼ 24% reduction,
P ¼ .03. Presented are the mean and standard deviation (SD)
of thymidine counts conducted in triplicate. Data are repre-
sentative of three independent experiments. Statistical sig-
niﬁcance was determined using the Holm-Sidak method, with
alpha ¼ 5.000% (P < .05). Each titration was analyzed indi-
vidually, without assuming a consistent SD.
Supplementary Figure 5. KLF14 KO associates with
H3K9me2 histone marks at the TSDR. Semiquantitative
PCR ChIP analysis of the expression of FOXP3 in cell frac-
tions after immunoprecipitation for H3K9me2 shows higher
levels of the modiﬁcation in KLF14 KO naïve cells stimulated
in T regulatory (Treg) conditions for 24 hours in comparison
with WT cells, inverse to the H3K9me3 mark. Data are
representative of three independent experiments.
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